Glen Tullman

Look there are a lot of people talking about innovation. But, you’ve got to be out there, and you have to make it happen at scale… and that’s what people have trouble doing.
— Glen Tullman

Advice for health tech startups from someone who should know. Glen Tullman is CEO of Livongo, a healthcare IT startup that rang in 2018 with a $105M mega-round raised internally among its current pool of investors at two-and-a-half times the company’s previous valuation. What can you learn from Glen’s story about how to scale? Find out his plans for using his new funding to fuel Livongo’s growth and expand out from diabetes management into other aspects of health. As the guy who took Allscripts to a wildly successful IPO, Glen talks to about being ready to go public and whether or not startups should 'build' for their exit. 

Nightingale Health

We provide over 200 biomarkers – so over 50xs more data than the current cholesterol test – and we can do it at the same price level.
— Kristiina Tolvanen

Today's cholesterol test is about to be disrupted. Finnish startup, Nightingale Health has developed a blood test that collects 50 times more biomarker data than that old test -- and they're offering it to labs at the same price point. 

Already the new test is boasting a 20% better prediction rate for diabetes and cardiovascular disease than the traditional test, with more work being done with research institutions and universities to build that evidence base.

The company is working off a $30M round but what's next as they look expand out of Europe and open labs in the US and Asian markets? Hint: They're looking to expand the understanding of the biomarkers their test provides by analyzing 500,000 blood samples from the UK Biobank. Listen in then find out more at 

Marvin Liao

Frankly speaking, the whole system is so broken and in need for innovation that every area is super interesting...every area is broken. Completely broken. And so from an investor perspective that’s a huge opportunity.

What’s the investment opportunity in digital health? Marvin Liao is partner at 500 Startups, a VC fund and accelerator program that has made more than 2000 investments in early stage tech startups over the past eight years. Healthcare technology being one of their areas of expertise, Marvin talks about whether or not he thinks digital therapeutics, mental health, and biotech have room to grow and if Apple, Google, and Amazon really have the power to change the future of health. Find out if he’s bullish on tech outside the US and why he’s got his eye on bleeding edge innovations coming out of Japan. 

Susannah Fox

This is the generation that we all really need to learn from because they’re using social media and digital tools in ways that are creative...
— Susannah Fox

Susannah Fox, former Chief Technology Officer for the US Department of Health & Human Services (HHS) talks about the latest research project she's working on - a survey that seeks to understand how 14-22 year old's use digital health and social media as tools for improving their well-being. Output from her data is expected to not only inform our understanding of the emerging trend of 'peer-to-peer health' but how adults can learn 'best practices' for using social media from a generation that has never lived without it.